Royal Bank of Canada Forecasts Strong Price Appreciation for Abbott Laboratories (NYSE:ABT) Stock

Abbott Laboratories (NYSE:ABT – Free Report) had its price target hoisted by Royal Bank of Canada from $140.00 to $145.00 in a research report report published on Thursday,Benzinga reports. They currently have an outperform rating on the healthcare product maker’s stock. Several other equities analysts have also commented on ABT. StockNews.com lowered Abbott Laboratories from […]